Bangladesh’s International Centre for Diarrheal Disease Research Launches Phase II Ivermectin Clinical Trial

Bangladesh’s International Centre for Diarrheal Disease Research Launches Phase II Ivermectin Clinical Trial

That Bangladesh could become a future hub of clinical research is palpable based on a number of unfolding trends.  TrialSite News discussed the nation of nearly 165 million—the 8th most populated in the world—with a dynamic and rapidly growing economy, innovative and entrepreneurial culture and remarkably robust pharmaceutical sector. During COVID-19, an intense drive for economical and pragmatic solutions to propel its people and economy opened the physician and research community to the potential of ivermectin as a prospective treatment for those ill with the novel coronavirus. In fact, TrialSite News had the privilege to interview a wonderful physician named Dr. Tarek Alam who reported “astounding results” with a hospital protocol study of ivermectin in COVID-19 patients at Bangladesh Medical College. Dr. Alam acknowledged the need for randomized controlled studies, mentioning his collaboration with an international research institute called ICDDRB. They have now, in fact, launched an ivermectin clinical trial.

The Study

By leveraging Dr. Alam’s successful protocol from the Bangladesh Medical College, ICDDRB’s study is titled Efficacy and Safety of Ivermectin and Doxycycl...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee